Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00021_DB00662_nanopub.RA0KFH31S_7PRvp41eNYy2C86sZ7KEMTm9RQkTxXJUiGI#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00021_DB00662 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00021_DB00662 label "DDI between Secretin and Trimethobenzamide - The stimulatory effect of Secretin may be reduced by anticholinergics such as Trimethobenzamide. Concomitant use of Secretin and drugs with substantial anticholinergic effects should be avoided. If combination therapy must be used, Secretin efficacy should be closely monitored. [drugbank_resource:DB00021_DB00662]" assertion.
- drugbank_resource:DB00021_DB00662 identifier "drugbank_resource:DB00021_DB00662" assertion.
- drugbank_resource:DB00021_DB00662 title "DDI between Secretin and Trimethobenzamide - The stimulatory effect of Secretin may be reduced by anticholinergics such as Trimethobenzamide. Concomitant use of Secretin and drugs with substantial anticholinergic effects should be avoided. If combination therapy must be used, Secretin efficacy should be closely monitored." assertion.
- drugbank:DB00662 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00021_DB00662 assertion.
- drugbank:DB00021 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00021_DB00662 assertion.